Elitecon International Ltd
Incorporated in 1987, Elitecon International Ltd is in the business of tobacco and allied products[1]
- Market Cap ₹ 8,717 Cr.
- Current Price ₹ 54.5
- High / Low ₹ 423 / 26.6
- Stock P/E 27.2
- Book Value ₹ 2.16
- Dividend Yield 0.09 %
- ROCE %
- ROE 43.5 %
- Face Value ₹ 1.00
Pros
Cons
- Stock is trading at 25.2 times its book value
- Promoter holding has decreased over last 3 years: -31.1%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2025 | TTM | |
|---|---|---|---|---|
| 1 | 1 | 549 | 4,771 | |
| 1 | 1 | 480 | 4,367 | |
| Operating Profit | 0 | 0 | 69 | 404 |
| OPM % | 2% | 4% | 13% | 8% |
| -0 | 0 | 3 | 12 | |
| Interest | 0 | 0 | 0 | 35 |
| Depreciation | 0 | 0 | 2 | 6 |
| Profit before tax | -0 | 0 | 70 | 375 |
| Tax % | 40% | 50% | -0% | |
| -0 | 0 | 70 | 336 | |
| EPS in Rs | 0.03 | 0.44 | 2.01 | |
| Dividend Payout % | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 83% |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 117% |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 109% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 43% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|
| Equity Capital | 1 | 1 | 160 | 160 |
| Reserves | 2 | 2 | 0 | 186 |
| 0 | 0 | 3 | 376 | |
| 1 | 1 | 88 | 1,188 | |
| Total Liabilities | 4 | 4 | 251 | 1,909 |
| 0 | 0 | 9 | 109 | |
| CWIP | 0 | 0 | 8 | 0 |
| Investments | 0 | 0 | 0 | 0 |
| 4 | 4 | 233 | 1,800 | |
| Total Assets | 4 | 4 | 251 | 1,909 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2025 | |
|---|---|---|---|
| -2 | -0 | -0 | |
| 0 | -0 | -20 | |
| 3 | 0 | 21 | |
| Net Cash Flow | 0 | -0 | 1 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2025 | |
|---|---|---|---|
| Debtor Days | 0 | 242 | 83 |
| Inventory Days | 167 | 120 | 33 |
| Days Payable | 0 | 45 | 60 |
| Cash Conversion Cycle | 167 | 317 | 56 |
| Working Capital Days | 635 | 890 | 93 |
| ROCE % | 1% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Purchase of Stock-In-Trade (Trading Era) INR ・Standalone data |
|
|||||||||
| Cigarette Manufacturing Capacity Million sticks per month ・Standalone data |
||||||||||
| Direct and Indirect Employment Support Number of Individuals |
||||||||||
| Geographic Presence (Countries) Number |
||||||||||
| Manufacturing Facility Size Sq. Ft. ・Standalone data |
||||||||||
| Product Portfolio Size Number of Products |
||||||||||
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
2d - Submission of Copies of Publication of Elitecon International Limited ('the Company') under Regulation 30 read with Regulation 47 of SEBI (LODR) Regulation, 2015
-
Financial Results For The Quarter And Nine Months Ended December 31, 2025.
7 Mar - Board approved unaudited standalone and consolidated results for quarter and nine months ended Dec 31, 2025.
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On March 07, 2026.
7 Mar - Board approved standalone and consolidated unaudited results for quarter and nine months ended Dec 31, 2025; limited review attached.
-
Board Meeting Intimation for Prior Intimation Of Board Meeting Of Elitecon International Limited ('The Company')
2 Mar - Board meeting Mar 7, 2026 to approve unaudited Q3 and nine-month results for period ended Dec 31, 2025.
-
Revised Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 (LODR).
2 Mar - FDA Nashik inspected plant on Jan 08, 2026; inventories and one packing/sealing machine seized; matter under review.
Annual reports
Concalls
-
Aug 2025TranscriptAI SummaryPPT
Business Overview:[1]
EIL manufactures and trades tobacco-based products for both domestic and international markets. The company currently operates in overseas markets including the UAE, Singapore, Hong Kong, and European countries like the UK. It plans to expand its product range to include items like chewing tobacco, snuff grinders, match lights, matches, matchboxes, pipes, and other related articles.